{"resourceType":"Bundle","type":"searchset","entry":[{"resource":{"resourceType":"Parameters","parameter":[{"name":"recommendation","resource":{"resourceType":"ImmunizationRecommendation","patient":{"reference":"Patient/2013-0444"},"recommendation":[{"date":"2011-08-21T00:00:00.000","forecastStatus":{"coding":[{"system":"http://hl7.org/fhir/us/ImmunizationFHIRDS/CodeSystem/ForecastStatus","code":"complete","display":"Complete"}]},"dateCriterion":[{"code":{"coding":[{"system":"http://loinc.org","code":"30981-5","display":"Earliest date to give"}]},"value":"2999-12-31T00:00:00.000"},{"code":{"coding":[{"system":"http://loinc.org","code":"30980-7","display":"Date vaccine due"}]},"value":"2999-12-31T00:00:00.000"},{"code":{"coding":[{"system":"http://loinc.org","code":"59778-1","display":"Date when overdue for immunization"}]},"value":"2999-12-31T00:00:00.000"}],"protocol":{"description":"Evaluation_Test_Type: Interval: At Minimum\nForecast_Test_Type: EvaluationNot recommended: series complete\nGeneral_Description: This test case describes when a child is administered the third dose of the HPV vaccine at 12 weeks from dose number 2 and at least 16 weeks - 4 days from dose number one, that the dose is considered to be valid.  The series is complete. (Prior to 12/16/16, 16 weeks - 4 days was allowed to be used as an Absolute Minimum Interval from Target Dose #1, and 12 weeks -4 days was allowed to be used as an Absolute Minimum Interval from Target Dose #2).","series":"HPV"}}]}}]},"request":{"method":"PUT","url":"Parameters"}}]}